4 unknown. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow HIV Infection: new trials by email Literature Review of HIV Infection trials Research Report on HIV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient Injection of protein purified derivative - Anogenital Warts, HIV Infection | Phase 2 / Phase 3 | Unknown | Universitas Padjadjaran | 30 | 2024-09-15 | 2024-09-19 |
| Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa adherence reinforcement, Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators) - HIV Infection | Phase 2 | Unknown | ANRS, Emerging Infectious Diseases | 201 | 2013-03-01 | 2017-02-17 |
| Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection Nitazoxanide - HCV Coinfection, HIV Infection | Phase 2 | Unknown | Juan Macías | 45 | 2012-02-01 | 2015-01-14 |
| Safety and Efficacy of T Cell Genetic Immunotherapy for HIV VRX496-Modified Autologous T cells - HIV Infection | Phase 2 | Unknown | VIRxSYS Corporation | 60 | 2005-07-01 | 2011-06-08 |
HIV Infections (4) · Condylomata Acuminata (1)
Blood-Borne Infections (4) · Communicable Diseases (4) · Genital Diseases (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Infections (4) · Lentivirus Infections (4) · RNA Virus Infections (4) · Retroviridae Infections (4) · Sexually Transmitted Diseases (4) · Sexually Transmitted Diseases, Viral (4) · Urogenital Diseases (4) · Virus Diseases (4) · DNA Virus Infections (1) · Disease Attributes (1)
Raltegravir Potassium (1) · nitazoxanide (1)
ANRS, Emerging Infectious Diseases (1) · Juan Macías (1) · Universitas Padjadjaran (1) · VIRxSYS Corporation (1)
Burkina Faso (1) · Côte d’Ivoire (1) · Mali (1) · Senegal (1) · Spain (1) · United States (1)
Pierre-Marie Girard, MD, PhD (1) · Roland Landman, MD (1) · Serge P. Eholie, MD, MSc, Pr (1) · Tessio Rebello, PhD (1) · Xavier Anglaret, MD, PhD (1)